2 Years Since Marijuana Legalization: Here’s How Canada’s Top Stocks Have Done

You probably would’ve been better off avoiding Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and other pot stocks over the past couple of years.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Oct. 17, 2018, is when the recreational marijuana industry officially opened for business in Canada. It’s been a topsy-turvy time since then. Investors have seen sky-high valuations crumble over the years, and the CannTrust scandal has destroyed a lot of the confidence investors had in the industry. Bruce Linton, who’s able to put a stock on the map just by wearing its t-shirt, was arguably the icon of the industry, and he was unceremoniously removed from his position as CEO at Canopy Growth (TSX:WEED)(NYSE:CGC) over a year ago. Those are just some of the most newsworthy developments to have taken place over the past two years.

If you were bullish on the cannabis industry, you may have been tempted to invest in it. With the industry legal, there were high expectations for growth. There was just one big problem: valuations were already out of control. At more than $20 billion, Canopy Growth was grossly overvalued in 2019, as it continued to rise in the legal industry’s early stages. But a correction was overdue and as Canopy Growth tumbled, so too did its peers.

Here’s how much you’d have left on a $10,000 investment in Canada’s top pot stocks

Let’s look at a scenario where you invested $10,000 in some of the top pot stocks just before legalization took place, and what the value of those holdings would be today.

Oct. 16, 2018 Share Price Shares Owned Oct 16, 2020 Share Price Portfolio Value Loss
Canopy Growth $68.70 146 $23.47 $3,426.62 $6,573.38
Aphria $18.69 535 $6.13 $3,279.55 $6,720.45
OrganiGram $7.29 1372 $1.55 $2,126.60 $7,873.40
HEXO $8.23 1215 $0.99 $1,202.85 $8,797.15
Aurora Cannabis $13.98* 715 $0.44* $314.60 $9,685.40

*Price when factoring out the stock’s 12-for-1 reverse split.

Regardless of which Canadian pot stock you invested in two years ago, you’d likely have a big dent in your portfolio if you held on until now. Even the industry leaders at the time, Canopy Growth and Aurora Cannabis, have suffered significant losses in the years since legalization. Concerns surrounding profitability and sometimes even liquidity have put investors on edge. Even with a big investor like Constellation Brands backing Canopy Growth, that hasn’t been enough to make it a stable buy.

By no means does this mean that these stocks can’t recover from their significant declines, but investors should be very careful investing in what’s been an erratic industry in recent years. Promises of future growth are meaningless if companies aren’t able to deliver the results.

Should you steer clear of pot stocks?

For many conservative, risk-averse investors, the short answer to this question is definitely “yes.” Although lots of growth exists in the cannabis industry, it could look a whole lot different in the next few years. Consolidation is inevitable, as some cannabis companies may not have enough cash to stay afloat amid a pandemic and a recession. And with stock prices a fraction of what they were worth a few years ago, dipping into the equity markets to raise cash isn’t an attractive option anymore.

If you’re investing in cannabis, you need to be aware of the significant risks involved when doing so. There’s no guarantee that these stocks have stopped falling in value or that they’ll even be around in a few years.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands and OrganiGram Holdings. The Motley Fool recommends HEXO., HEXO., and OrganiGram Holdings.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »